| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024028 |
| Receipt No. | R000027631 |
| Scientific Title | Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterol |
| Date of disclosure of the study information | 2016/09/14 |
| Last modified on | 2021/05/06 (Ver. 6) |
| Basic information | ||
| Public title | Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterol | |
| Acronym | Clinical trials of lipid improvement effect of Goishi tea | |
| Scientific Title | Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterol | |
| Scientific Title:Acronym | Clinical trials of lipid improvement effect of Goishi tea | |
| Region |
|
|
| Condition | ||
| Condition | Healthy individual | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluate the LDL lowering effect of the intake of Goishi tea |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | LDL-CHO |
| Key secondary outcomes | Height,Weight, Blood pressure,
T-CHO,HDL-CHO,TP,T-BIL,UN,CRE,UA,ALT,AST, alpha-GTP,ALP,LD,CK,ChE,AMY,Na, K,Cl,Ca, Fe,Blood sugar,HbA1c,CBC |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects drink 195g (about 195mL) Goishi tea twice a day for 12 weeks. | |
| Interventions/Control_2 | The subjects drink 195g (about 195mL) placebo twice a day for 12 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Healthy adults
2. If you sign a consent document, you will be in 65 years or less, and 20 years of age or older 3. The person who have pointed out that high cholesterol in the past year, and who recommended a diet and exercise therapy 4. If LDL cholesterol value of screening tests is greater than or equal to 120mg / dL |
|||
| Key exclusion criteria | 1. Minors
2. Maternal and lactating women 3. The person who is suffering from some sort of disease 4. The person who drink on a daily basis Goishi tea 5. The person principal investigator has determined that inappropriate |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kochi medical school hospital | ||||||
| Division name | pharmacy | ||||||
| Zip code | |||||||
| Address | 185-1, Kohasu, Oko, Nankoku, Kochi, Japan | ||||||
| TEL | 088-880-2549 | ||||||
| miyamus@kochi-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kochi medical school hospital | ||||||
| Division name | pharmacy | ||||||
| Zip code | |||||||
| Address | 185-1, Kohasu, Oko, Nankoku, Kochi, Japan | ||||||
| TEL | 088-880-2549 | ||||||
| Homepage URL | |||||||
| jm-kouheij@kochi-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kochi medical school hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otoyo yutori farm |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027631 |